{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:03:40Z","timestamp":1791201820214,"version":"4.2.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/npp.2013.297","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T05:43:46Z","timestamp":1382593426000},"page":"973-980","source":"Crossref","is-referenced-by-count":62,"title":["Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms"],"prefix":"10.1038","volume":"39","author":[{"given":"Lina","family":"Chiuccariello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo M","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Rajkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"BFnpp2013297_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/archgenpsychiatry.2011.82","volume":"68","author":"I Bacher","year":"2011","unstructured":"Bacher I, Houle S, Xu X, Zawertailo L, Soliman A, Wilson AA et al (2011). Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch General Psychiatry 68: 817\u2013826.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2013297_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/archgenpsychiatry.2007.11","volume":"65","author":"DA Barton","year":"2008","unstructured":"Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C et al (2008). Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch General Psychiatry 65: 38\u201346.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2013297_CR3","first-page":"1","volume":"43C","author":"B Dunjic-Kostic","year":"2012","unstructured":"Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A et al (2012). Melancholic and atypical major depression\u2014Connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry 43C: 1\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2013297_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(01)02495-8","volume":"321","author":"ML Filipenko","year":"2002","unstructured":"Filipenko ML, Beilina AG, Alekseyenko OV, Dolgov VV, Kudryavtseva NN (2002). Repeated experience of social defeats increases serotonin transporter and monoamine oxidase A mRNA levels in raphe nuclei of male mice. Neurosci Lett 321: 25\u201328.","journal-title":"Neurosci Lett"},{"key":"BFnpp2013297_CR5","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1471-4159.2007.04921.x","volume":"103","author":"JC Fitzgerald","year":"2007","unstructured":"Fitzgerald JC, Ufer C, De Girolamo LA, Kuhn H, Billett EE (2007). Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells. J Neurochem 103: 2189\u20132199.","journal-title":"J Neurochem"},{"key":"BFnpp2013297_CR6","doi-asserted-by":"publisher","first-page":"14065","DOI":"10.1073\/pnas.93.24.14065","volume":"93","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C et al (1996). Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93: 14065\u201314069.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2013297_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJM195412162512504","volume":"251","author":"ED Freis","year":"1954","unstructured":"Freis ED (1954). Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 251: 1006\u20131008.","journal-title":"N Engl J Med"},{"key":"BFnpp2013297_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.jcbfm.9600197","volume":"26","author":"N Ginovart","year":"2006","unstructured":"Ginovart N, Meyer JH, Boovariwala A, Hussey D, Rabiner EA, Houle S et al (2006). Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain. J Cereb Blood Flow Metab 26: 330\u2013344.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2013297_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/sj.mp.4001032","volume":"7","author":"PW Gold","year":"2002","unstructured":"Gold PW, Chrousos GP (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states. Mol Psychiatry 7: 254\u2013275.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2013297_CR10","doi-asserted-by":"publisher","first-page":"24195","DOI":"10.1074\/jbc.M112.373936","volume":"287","author":"M Grunewald","year":"2012","unstructured":"Grunewald M, Johnson S, Lu D, Wang Z, Lomberk G, Albert PR et al (2012). Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression. J Biol Chem 287: 24195\u201324206.","journal-title":"J Biol Chem"},{"key":"BFnpp2013297_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/sj.mp.4001755","volume":"11","author":"J Harlan","year":"2006","unstructured":"Harlan J, Chen Y, Gubbins E, Mueller R, Roch JM, Walter K et al (2006). Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol Psychiatry 11: 76\u201385.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2013297_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nature04250","volume":"438","author":"I Hovatta","year":"2005","unstructured":"Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM et al (2005). Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438: 662\u2013666.","journal-title":"Nature"},{"key":"BFnpp2013297_CR13","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/npp.2011.105","volume":"36","author":"S Johnson","year":"2011","unstructured":"Johnson S, Stockmeier CA, Meyer JH, Austin MC, Albert PR, Wang J et al (2011). The reduction of R1, a novel repressor protein for monoamine oxidase a, in major depressive disorder. Neuropsychopharmacology 36: 2139\u20132148.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013297_CR14","doi-asserted-by":"publisher","first-page":"10065","DOI":"10.1523\/JNEUROSCI.19-22-10065.1999","volume":"19","author":"N Kajimura","year":"1999","unstructured":"Kajimura N, Uchiyama M, Takayama Y, Uchida S, Uema T, Kato M et al (1999). Activity of midbrain reticular formation and neocortex during the progression of human non-rapid eye movement sleep. J Neurosci 19: 10065\u201310073.","journal-title":"J Neurosci"},{"key":"BFnpp2013297_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.psychres.2011.12.007","volume":"198","author":"D Karlovic","year":"2012","unstructured":"Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D (2012). Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry research 198: 74\u201380.","journal-title":"Psychiatry research"},{"key":"BFnpp2013297_CR16","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1176\/appi.ajp.159.11.1830","volume":"159","author":"M Liotti","year":"2002","unstructured":"Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P (2002). Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159: 1830\u20131840.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013297_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-0327(94)90015-9","volume":"32","author":"J Lonnqvist","year":"1994","unstructured":"Lonnqvist J, Sihvo S, Syvalahti E, Kiviruusu O (1994). Moclobemide and fluoxetine in atypical depression: a double-blind trial. J Affect Disord 32: 169\u2013177.","journal-title":"J Affect Disord"},{"key":"BFnpp2013297_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1126\/science.1104343","volume":"307","author":"BB Lowell","year":"2005","unstructured":"Lowell BB, Shulman GI (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307: 384\u2013387.","journal-title":"Science"},{"key":"BFnpp2013297_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/ajp.150.1.118","volume":"150","author":"PJ McGrath","year":"1993","unstructured":"McGrath PJ, Stewart JW, Nunes EV, Ocepek-Welikson K, Rabkin JG, Quitkin FM et al (1993). A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry 150: 118\u2013123.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013297_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/clpt.2011.285","volume":"91","author":"JH Meyer","year":"2012","unstructured":"Meyer JH (2012). Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention. Clin Pharmacol Ther 91: 201\u2013214.","journal-title":"Clin Pharmacol Ther"},{"key":"BFnpp2013297_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","volume":"63","author":"JH Meyer","year":"2006","unstructured":"Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A et al (2006). Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch General Psychiatry 63: 1209\u20131216.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2013297_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/archgenpsychiatry.2009.156","volume":"66","author":"JH Meyer","year":"2009","unstructured":"Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM et al (2009). Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch General Psychiatry 66: 1304\u20131312.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2013297_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1471-4159.1979.tb02297.x","volume":"32","author":"DL Nelson","year":"1979","unstructured":"Nelson DL, Herbet A, Glowinski J, Hamon M (1979). [3H]Harmaline as a specific ligand of MAO A\u2014II. Measurement of the turnover rates of MAO A during ontogenesis in the rat brain. J Neurochem 32: 1829\u20131836.","journal-title":"J Neurochem"},{"key":"BFnpp2013297_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1126\/science.1094285","volume":"304","author":"J O'Doherty","year":"2004","unstructured":"O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ (2004). Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 304: 452\u2013454.","journal-title":"Science"},{"key":"BFnpp2013297_CR25","doi-asserted-by":"publisher","first-page":"21512","DOI":"10.1074\/jbc.M600250200","volume":"281","author":"XM Ou","year":"2006","unstructured":"Ou XM, Chen K, Shih JC (2006a). Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 281: 21512\u201321525.","journal-title":"J Biol Chem"},{"key":"BFnpp2013297_CR26","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.1073\/pnas.0601515103","volume":"103","author":"XM Ou","year":"2006","unstructured":"Ou XM, Chen K, Shih JC (2006b). Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci USA 103: 10923\u201310928.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2013297_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/er.2009-0027","volume":"31","author":"ME Patti","year":"2010","unstructured":"Patti ME, Corvera S (2010). The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31: 364\u2013395.","journal-title":"Endocr Rev"},{"key":"BFnpp2013297_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0165-1781(01)00301-8","volume":"104","author":"MA Posternak","year":"2001","unstructured":"Posternak MA, Zimmerman M (2001). Symptoms of atypical depression. Psychiatry Res 104: 175\u2013181.","journal-title":"Psychiatry Res"},{"key":"BFnpp2013297_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1192\/S0007125000292465","volume":"21","author":"FM Quitkin","year":"1993","unstructured":"Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K et al (1993). Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl 21: 30\u201334.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFnpp2013297_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/cercor\/5.4.307","volume":"5","author":"G Rajkowska","year":"1995","unstructured":"Rajkowska G, Goldman-Rakic PS (1995a). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5: 307\u2013322.","journal-title":"Cereb Cortex"},{"key":"BFnpp2013297_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cercor\/5.4.323","volume":"5","author":"G Rajkowska","year":"1995","unstructured":"Rajkowska G, Goldman-Rakic PS (1995b). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 5: 323\u2013337.","journal-title":"Cereb Cortex"},{"key":"BFnpp2013297_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2174\/13894501113149990156","volume":"14","author":"G Rajkowska","year":"2013","unstructured":"Rajkowska G, Stockmeier CA (2013). Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14: 1225\u20131236.","journal-title":"Curr Drug Targets"},{"key":"BFnpp2013297_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nn1944","volume":"10","author":"KJ Ressler","year":"2007","unstructured":"Ressler KJ, Mayberg HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10: 1116\u20131124.","journal-title":"Nat Neurosci"},{"key":"BFnpp2013297_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F et al (2006). An automated method for the extraction of regional data from PET images. Psychiatry Res 147: 79\u201389.","journal-title":"Psychiatry Res"},{"key":"BFnpp2013297_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archgenpsychiatry.2010.32","volume":"67","author":"J Sacher","year":"2010","unstructured":"Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM et al (2010). Elevated brain monoamine oxidase A binding in the early postpartum period. Arch General Psychiatry 67: 468\u2013474.","journal-title":"Arch General Psychiatry"},{"key":"BFnpp2013297_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.brainres.2010.08.093","volume":"1359","author":"S Salim","year":"2010","unstructured":"Salim S, Asghar M, Chugh G, Taneja M, Xia Z, Saha K (2010). Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res 1359: 178\u2013185.","journal-title":"Brain Res"},{"key":"BFnpp2013297_CR37","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1523\/JNEUROSCI.12-05-01977.1992","volume":"12","author":"J Saura","year":"1992","unstructured":"Saura J, Kettler R, Da Prada M, Richards JG (1992). Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci 12: 1977\u20131999.","journal-title":"J Neurosci"},{"key":"BFnpp2013297_CR38","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/npp.2011.151","volume":"36","author":"HD Schmidt","year":"2011","unstructured":"Schmidt HD, Shelton RC, Duman RS (2011). Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 36: 2375\u20132394.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013297_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0361-9230(98)00111-7","volume":"47","author":"TA Slotkin","year":"1998","unstructured":"Slotkin TA, Seidler FJ, Ritchie JC (1998). Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull 47: 345\u2013348.","journal-title":"Brain Res Bull"},{"key":"BFnpp2013297_CR40","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1176\/ajp.155.10.1398","volume":"155","author":"PF Sullivan","year":"1998","unstructured":"Sullivan PF, Kessler RC, Kendler KS (1998). Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. Am J Psychiatry 155: 1398\u20131406.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013297_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1017\/S1461145707007894","volume":"11","author":"A Thalmeier","year":"2008","unstructured":"Thalmeier A, Dickmann M, Giegling I, Schneider B, M Hartmann A, Maurer K et al (2008). Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 11: 217\u2013228.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2013297_CR42","first-page":"5","volume":"53","author":"ME Thase","year":"1992","unstructured":"Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ (1992). Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 53: 5\u201311.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2013297_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28\u201340.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013297_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2010.04.012","volume":"183","author":"HB Uylings","year":"2010","unstructured":"Uylings HB, Sanz-Arigita EJ, de Vos K, Pool CW, Evers P, Rajkowska G (2010). 3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI. Psychiatry Res 183: 1\u201320.","journal-title":"Psychiatry Res"},{"key":"BFnpp2013297_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0091-3057(02)01028-6","volume":"74","author":"NP Verhoeff","year":"2003","unstructured":"Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L et al (2003). Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav 74: 425\u2013432.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013297_CR46","unstructured":"WHO (2008). The Global Burden of Disease: 2004 Update World Health Organization."},{"key":"BFnpp2013297_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Edmondson D, Tipton KF (2006). The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7: 295\u2013309.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2013297_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00431803","volume":"87","author":"SN Young","year":"1985","unstructured":"Young SN, Smith SE, Pihl RO, Ervin FR (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 87: 173\u2013177.","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013297","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:46:28Z","timestamp":1684439188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFnpp2013297"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.297","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]}}}